FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Alvogen Recalls Mislabeled Fentanyl Product

Alvogen recalls two lots of fentanyl transdermal system 12 mcg/h transdermal patches due to a labeling error.

Human Drugs

Study on Compounded Bioidentical Hormones

FDA announces that the National Academies of Science, Engineering, and Medicine (NASEM) is conducting a study to examine the clinical utility of treat...

Human Drugs

Molecular Templates IND for MT-5111

FDA accepts a Molecular Templates IND application for MT-5111, an engineered toxin body targeting HER2-positive solid tumors.

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 4/19/2019.

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 4/19.

Federal Register

Assessment of Quantitative Imaging Devices Guide

Federal Register notice: FDA makes available a draft guidance entitled Technical Performance Assessment of Quantitative Imaging in Premarket Device Su...

Federal Register

Draft Guide on Nitinol-Containing Medical Devices

Federal Register notice: FDA announces the availability of a draft guidance entitled Technical Considerations for Non-Clinical Assessment of Medical D...

Federal Register

Guide on Bispecific Antibody Development Programs

Federal Register notice: FDA makes available a draft guidance entitled Bispecific Antibody Development Programs.

Human Drugs

Teva Gains Approval for First Generic Narcan

FDA approves a Teva Pharmaceuticals ANDA for the first generic naloxone hydrochloride nasal spray (Adapt Pharmas Narcan), indicated for stopping or re...

Human Drugs

Safety Concerns with Pfizer/Lilly Trial of Tanezumab

Pfizer and Eli Lilly report safety concerns with a Phase 3 study comparing tanezumab 2.5 mg and 5 mg with nonsteroidal anti-inflammatory drugs in pati...